Epiminder America, Inc.
Clinical trials sponsored by Epiminder America, Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New scalp implant may unlock better epilepsy care for hard-to-diagnose patients Results expected Jun 2027 (estimated)
-
New brain device helps doctors tame Hard-to-Track seizures
Disease control Recruiting nowThis study follows 210 people with epilepsy who already have the Minder device implanted. The device helps doctors make better treatment decisions by detecting seizures that standard tests miss. Participants will be monitored every six months for two years to see how the device i…
Sponsor: Epiminder America, Inc. • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New scalp implant may unlock better epilepsy care for hard-to-diagnose patients
Knowledge-focused Recruiting nowThis study looks at whether a device called the Minder, implanted under the scalp, can help doctors make better treatment plans for people with epilepsy whose standard brain wave tests (EEG) are not clear. About 210 adults with drug-resistant epilepsy will either get the Minder d…
Sponsor: Epiminder America, Inc. • Aim: Knowledge-focused
Last updated Jul 17, 2026 00:00 UTC